These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 27587205)

  • 21. The cost-effectiveness of four treatments for marijuana dependence.
    Olmstead TA; Sindelar JL; Easton CJ; Carroll KM
    Addiction; 2007 Sep; 102(9):1443-53. PubMed ID: 17645430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial.
    Barrowclough C; Marshall M; Gregg L; Fitzsimmons M; Tomenson B; Warburton J; Lobban F
    Psychol Med; 2014 Oct; 44(13):2749-61. PubMed ID: 25065535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.
    McRae-Clark AL; Baker NL; Gray KM; Killeen TK; Wagner AM; Brady KT; DeVane CL; Norton J
    Drug Alcohol Depend; 2015 Nov; 156():29-37. PubMed ID: 26386827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence.
    Carroll KM; Easton CJ; Nich C; Hunkele KA; Neavins TM; Sinha R; Ford HL; Vitolo SA; Doebrick CA; Rounsaville BJ
    J Consult Clin Psychol; 2006 Oct; 74(5):955-66. PubMed ID: 17032099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study.
    Miranda R; Treloar H; Blanchard A; Justus A; Monti PM; Chun T; Swift R; Tidey JW; Gwaltney CJ
    Addict Biol; 2017 May; 22(3):779-790. PubMed ID: 26752416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Web-Based Self-Help Intervention With and Without Chat Counseling to Reduce Cannabis Use in Problematic Cannabis Users: Three-Arm Randomized Controlled Trial.
    Schaub MP; Wenger A; Berg O; Beck T; Stark L; Buehler E; Haug S
    J Med Internet Res; 2015 Oct; 17(10):e232. PubMed ID: 26462848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex- and Gender-Based Analysis in Cannabis Treatment Outcomes: A Systematic Review.
    Brabete AC; Greaves L; Hemsing N; Stinson J
    Int J Environ Res Public Health; 2020 Jan; 17(3):. PubMed ID: 32019247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventions for cannabis use disorder.
    Winters KC; Mader J; Budney AJ; Stanger C; Knapp AA; Walker DD
    Curr Opin Psychol; 2021 Apr; 38():67-74. PubMed ID: 33338844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis Epidemiology: A Selective Review.
    Anthony JC; Lopez-Quintero C; Alshaarawy O
    Curr Pharm Des; 2017 Jan; 22(42):6340-6352. PubMed ID: 27526792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contingency Management for Cannabis Use Disorder Treatment.
    Lima MG; Tardelli VS; Fidalgo TM
    Eur Addict Res; 2024 Oct; ():1-17. PubMed ID: 39374591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Totality of the Evidence Suggests Prenatal Cannabis Exposure Does Not Lead to Cognitive Impairments: A Systematic and Critical Review.
    Torres CA; Medina-Kirchner C; O'Malley KY; Hart CL
    Front Psychol; 2020; 11():816. PubMed ID: 32457680
    [No Abstract]   [Full Text] [Related]  

  • 32. The Effects of Cannabis: Implications for the Surgical Patient.
    Copeland-Halperin LR; Herrera-Gomez LC; LaPier JR; Shank N; Shin JH
    Plast Reconstr Surg Glob Open; 2021 Mar; 9(3):e3448. PubMed ID: 33747688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral Treatments for Adolescent Cannabis Use Disorder: a Rationale for Cognitive Retraining.
    Aguinaldo LD; Squeglia LM; Gray KM; Coronado C; Lees B; Tomko RL; Jacobus J
    Curr Addict Rep; 2019 Dec; 6(4):437-442. PubMed ID: 32257767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Cannabis in the Incidence of Myocardial Infarction: A Review.
    Banerjee A; Gandhi AB; Antony I; Alexander J; Hisbulla M; Kannichamy V; Kaleem I; Mishra V; Khan S
    Cureus; 2020 Oct; 12(10):e11097. PubMed ID: 33240693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy for the Treatment of Cannabis Use Disorder.
    Kansagara D; Kondo KK; Morasco BJ; Nugent SM; Ayers CK
    Ann Intern Med; 2020 Aug; 173(3):248-249. PubMed ID: 32745455
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacotherapy for the Treatment of Cannabis Use Disorder.
    Brezing CA; Levin FR
    Ann Intern Med; 2020 Aug; 173(3):247-248. PubMed ID: 32745456
    [No Abstract]   [Full Text] [Related]  

  • 37. Correction to: Availability of legalized cannabis reduces demand for illegal cannabis among Canadian cannabis users: evidence from a behavioural economic substitution paradigm.
    Amlung M; MacKillop J
    Can J Public Health; 2019 Aug; 110(4):527-528. PubMed ID: 31187462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid Agonist Reduces Cannabis Use.
    Slomski A
    JAMA; 2019 Sep; 322(12):1134. PubMed ID: 31550029
    [No Abstract]   [Full Text] [Related]  

  • 39. Correction to: Cannabis and public health-a need to reclaim the narrative.
    Smyth BP; Cannon M
    Ir J Med Sci; 2022 Apr; 191(2):967. PubMed ID: 34019226
    [No Abstract]   [Full Text] [Related]  

  • 40. Cannabis for Cognitive Enhancement as a New Coping Strategy? Results From a Survey of Students at Four Universities in Germany.
    Franke AG; Roser P; Lieb K; Vollmann J; Schildmann J
    Subst Use Misuse; 2016 Dec; 51(14):1856-62. PubMed ID: 27607062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.